Ozer Baysal - Agenus Insider

Agenus Inc -- USA Stock  

USD 4.67  0.01  0.21%

Chief Bus. Officer

Mr. Ozer Baysal is Chief Commercial Officer, Head of HR of Agenus Inc. Mr. Baysal was Chief Business Officer since January 2013 until July 1, 2017. Prior to joining Agenus Mr. Baysal spent more than 30 years with Pfizer in a broad number of functional and geographic areas, most recently serving as President of Europe, Emerging Markets Region. While at Pfizer, he held key leadership positions in Marketing, Sales, and Manufacturing, and was actively involved with numerous licensing and MA activities
Age: 60  Executive Since 2017      
781-674-4400  www.agenusbio.com
Baysal holds a bachelor degree from Bosphorus University in Industrial Engineering and has completed the Programs for Leadership and Management Development at Harvard Business School.

Management Efficiency

The company has return on total asset (ROA) of (32.69) % which means that it has lost $32.69 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (421.01) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 139.14 M in liabilities. Agenus Inc has Current Ratio of 3.29 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Found 14 records

EXECUTIVE Since

Shayla ForsterVBI Vaccines Inc
2015
FRCPC MDDel Mar Pharmaceuticals Inc
N/A
Eric CrombezDimension Therapeutics Inc
2014
David ReckerVericel Corporation
2014
Jacob GeorgeVascular Biogenics Ltd
2000
Tien MDNantKwest Inc
N/A
Sam WadsworthDimension Therapeutics Inc
N/A
Eric MDDimension Therapeutics Inc
N/A
Mary ThistleDimension Therapeutics Inc
2017
David AndersonVBI Vaccines Inc
2015
Samuel WadsworthDimension Therapeutics Inc
2013
Ayelet HornVascular Biogenics Ltd
2007
Rishi GuptaDimension Therapeutics Inc
2015
Ross TuboVericel Corporation
2014

Entity Summary

Agenus Inc., an immunooncology company, focuses on the discovery and development of treatments that engage the body?s immune system for patients suffering with cancer. Agenus Inc (AGEN) is traded on Nasdaq Capital Markets in USA. It is located in MASSACHUSETTS, U.S.A and employs 224 people. Agenus is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Portfolio Center Now
   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
Hide  View All  Next  Launch Portfolio Center
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Agenus Inc to your portfolio

Top Management

Agenus Inc Leadership Team
Robert Stein, Executive, Ph.D
James Gorman, President
Ozer Baysal, Executive
Ulf Wiinberg, Director
Shalini Sharp, Director
Wadih Jordan, Director
Christine Klaskin, VP
Tom Dechaene, Director
Garo Armen, Chairman, Ph.D
JeanMarie Cuillerot, Executive
Brian Corvese, Director
Andrea Rabney, Executive
C Ballantyne, CFO
Karen Valentine, VP
Shahzad Malik, Director, Ph.D
Evan Ballantyne, CFO
Timothy Wright, Director

Stock Performance

Agenus Performance Indicators